Plasma and lipoprotein a-tocopherol concentrations of four patients with familial isolated vitamin E deficiency and six control subjects were observed for 4 d after an oral dose (-15 mg) of RRR-a-tocopheryl acetate labeled with six deuterium atoms (d6-tocopherol). Chylomicron d6-tocopherol concentrations were similar in the two groups. d6-Tocopherol concentrations of plasma, very low (VLDL), low (LDL), and high (HDL) density lipoproteins were similar in the two groups only during the first 12 h; then these were significantly lower, and the rate of disappearance faster, in the patients. The times (t.u) of the maximum chylomicron d6-tocopherol concentrations were similar for the two groups, but t1.,,, values in the controls increased in the order: chylomicrons < VLDL . LDL -HDL, while the corresponding values in the patients were similar to the chylomicron t,. Thus, plasma d4-tocopherol in controls increased during chylomicron and VLDL catabolism, whereas in patients it increased only during chylomicron catabolism, thereby resulting in a premature and faster decline in the plasma tocopherol concentration due to a lack of d6-tocopherol secretion from the liver. We suggest that these patients are lacking or have a defective liver "tocopherol binding protein" that incorporates a-tocopherol into nascent VLDL. (J. Clin. Invest. 1990. 85:397-407.) deuterated a-tocopherol * tocopherol binding protein Introduction Humans do not readily become vitamin E deficient. It has been generally accepted that the quantities of vitamin E in the diet are adequate and that the vitamin E stores in the body are sufficient to prevent any symptoms of vitamin E deficiency from occurring even in the face of a prolonged absence of dietary vitamin E. However, vitamin E deficiency does occur in humans as a consequence ofa variety oflipid malabsorption syndromes, most notably as a result of cholestatic liver disease in children, and in the genetic disorders, abetalipoproteinemia and homozygous hypobetalipoproteinemia (as reviewed in 1).